These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy. Jellinger KA. Neurodegener Dis; 2008 Dec 01; 5(6):339-46. PubMed ID: 18349518 [Abstract] [Full Text] [Related]
30. Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy. Kertesz A, Munoz D. Dement Geriatr Cogn Disord; 2004 Dec 01; 17(4):282-6. PubMed ID: 15178937 [Abstract] [Full Text] [Related]
31. Action and object naming in frontotemporal dementia, progressive supranuclear palsy, and corticobasal degeneration. Cotelli M, Borroni B, Manenti R, Alberici A, Calabria M, Agosti C, Arévalo A, Ginex V, Ortelli P, Binetti G, Zanetti O, Padovani A, Cappa SF. Neuropsychology; 2006 Sep 01; 20(5):558-65. PubMed ID: 16938018 [Abstract] [Full Text] [Related]
32. Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank. Josephs KA, Dickson DW. Mov Disord; 2003 Sep 01; 18(9):1018-26. PubMed ID: 14502669 [Abstract] [Full Text] [Related]
33. [Progressive supranuclear palsy]. Hasegawa K. Rinsho Shinkeigaku; 1997 Dec 01; 37(12):1128-30. PubMed ID: 9577667 [Abstract] [Full Text] [Related]
34. Decreased beta-amyloid peptide42 in cerebrospinal fluid of patients with progressive supranuclear palsy and corticobasal degeneration. Noguchi M, Yoshita M, Matsumoto Y, Ono K, Iwasa K, Yamada M. J Neurol Sci; 2005 Oct 15; 237(1-2):61-5. PubMed ID: 15992827 [Abstract] [Full Text] [Related]
35. [Corticobasal degeneration and progressive supranuclear palsy--biochemical marker]. Urakami K, Nakashima K. Rinsho Shinkeigaku; 2002 Nov 15; 42(11):1162-4. PubMed ID: 12784694 [Abstract] [Full Text] [Related]
36. Staging disease severity in movement disorder tauopathies: brain atrophy separates progressive supranuclear palsy from corticobasal degeneration. Schofield EC, Caine D, Kril JJ, Cordato NJ, Halliday GM. Mov Disord; 2005 Jan 15; 20(1):34-9. PubMed ID: 15390131 [Abstract] [Full Text] [Related]
37. Corticobasal degeneration: an autopsy case clinically diagnosed as progressive supranuclear palsy. Shiozawa M, Fukutani Y, Sasaki K, Isaki K, Hamano T, Hirayama M, Imamura K, Mukai M, Arai N, Cairns NJ. Clin Neuropathol; 2000 Jan 15; 19(4):192-9. PubMed ID: 10919351 [Abstract] [Full Text] [Related]
38. EEG findings in early-stage corticobasal degeneration and progressive supranuclear palsy: a retrospective study and literature review. Tashiro K, Ogata K, Goto Y, Taniwaki T, Okayama A, Kira J, Tobimatsu S. Clin Neurophysiol; 2006 Oct 15; 117(10):2236-42. PubMed ID: 16920021 [Abstract] [Full Text] [Related]
39. Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration. Yoshida M. Neuropathology; 2014 Dec 15; 34(6):555-70. PubMed ID: 25124031 [Abstract] [Full Text] [Related]
40. [Contribution of oculomotor examination for the etiological diagnosis of parkinsonian syndromes]. Pierrot-Deseilligny Ch, Rivaud-Péchoux S. Rev Neurol (Paris); 2003 May 15; 159(5 Pt 2):3S75-81. PubMed ID: 12773891 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]